Table 1.
Treatment | No. rats examined | Drinking water intake (g/day) | Body weight (g) | Liver weight (g) | Relative liver weight (g/100 g body weight) | Length of the large bowel (cm) |
---|---|---|---|---|---|---|
AOM alone | 14 | 27.3 ± 1.3 | 203 ± 11 | 10.2 ± 1.0 | 5.0 ± 0.5 | 19.0 ± 1.8 |
AOM + 0.2% 1‐MT | 14 | 25.2 ± 2.3 | 198 ± 13* | 10.1 ± 0.7 | 5.1 ± 0.4 | 19.6 ± 1.1 |
AOM + 0.1% EGCG | 14 | 26.1 ± 2.9 | 202 ± 8 | 9.8 ± 0.8 | 4.9 ± 0.5 | 19.0 ± 0.9 |
0.2% 1‐MT | 6 | 25.3 ± 4.3 | 217 ± 12 | 10.6 ± 0.8 | 4.9 ± 0.2 | 20.3 ± 1.6 |
0.1% EGCG | 6 | 26.5 ± 1.4 | 212 ± 16 | 10.2 ± 0.9 | 4.8 ± 0.6 | 19.5 ± 1.1 |
No treatment | 6 | 26.8 ± 0.8 | 208 ± 9 | 9.6 ± 0.8 | 4.6 ± 0.4 | 19.0 ± 2.1 |
Data are given as the mean ± SD. *P < 0.05 compared with 0.2% 1‐methyltryptophan (1‐MT) alone. AOM, azoxymethane; EGCG, (−)‐epigallocatechin gallate.